Flore D. B.
- Country
- France
- Department
- 69
Research Overview
- Phase 2 Double-Masked Placebo-Controlled Dose-Finding Study of Danicopan in Geographic Atrophy Secondary to Age-Related Macular Degeneration
- Phase 3 Multicenter Randomized Double-Masked Placebo-Controlled Trial of Tinlarebant in Geographic Atrophy Treatment
- Evaluation of Spontaneous Retinal Arterial Pulsations as Prognostic Indicators in Central Retinal Vein Occlusion with Aflibercept Treatment
Data & Insights
Has run more than one trial at 64 of 122 partner sites.
Specializations
Retinal Degeneration and Geographic Atrophy
Flore De Bats is involved in clinical research focused on age-related macular degeneration with a strong emphasis on geographic atrophy, including dry forms of the disease and atrophy secondary to AMD.
- Geographic atrophy
- Dry age-related macular degeneration
- Geographic atrophy secondary to AMD
- Visual function preservation
The research landscape includes therapies targeting complement-mediated retinal injury and long-term disease control in progressive macular degeneration.
Neovascular Macular Disease
Her clinical trial activity also covers neovascular age-related macular degeneration and choroidal neovascularization secondary to pathologic myopia, with interest in treatments that reduce retinal fluid and support visual acuity.
- Neovascular age-related macular degeneration
- Wet AMD
- Choroidal neovascularization
- Anti-VEGF therapy
This area reflects engagement with intravitreal strategies and combination approaches for exudative retinal vascular disease.
Diabetic and Vascular Retinal Disorders
Flore De Bats contributes to studies in diabetic macular oedema and central retinal vein occlusion, two conditions that require attention to retinal edema, vascular compromise, and visual recovery.
- Diabetic macular oedema
- Central retinal vein occlusion
- Retinal edema
- Visual acuity outcomes
Her research interest includes therapies designed to stabilize retinal structure and improve functional vision in vascular retinal disease.
Glaucoma and Ocular Hypertension
Her portfolio includes trials in open-angle glaucoma and ocular hypertension, with a focus on intraocular pressure control and sustained ocular pressure-lowering treatment options.
- Open-angle glaucoma
- Ocular hypertension
- Intraocular pressure reduction
- Long-acting ocular therapies
This domain highlights interest in treatments supporting chronic pressure management and optic nerve protection.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.